annual CFF:
$748.46M+$296.92M(+65.76%)Summary
- As of today (May 29, 2025), BBIO annual cash flow from financing activities is $748.46 million, with the most recent change of +$296.92 million (+65.76%) on December 31, 2024.
- During the last 3 years, BBIO annual CFF has risen by +$12.01 million (+1.63%).
- BBIO annual CFF is now at all-time high.
Performance
BBIO Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$60.33M-$413.60M(-87.27%)Summary
- As of today (May 29, 2025), BBIO quarterly cash flow from financing activities is $60.33 million, with the most recent change of -$413.60 million (-87.27%) on March 31, 2025.
- Over the past year, BBIO quarterly CFF has dropped by -$219.22 million (-78.42%).
- BBIO quarterly CFF is now -88.99% below its all-time high of $547.91 million, reached on March 31, 2021.
Performance
BBIO quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$529.24M-$219.22M(-29.29%)Summary
- As of today (May 29, 2025), BBIO TTM cash flow from financing activities is $529.24 million, with the most recent change of -$219.22 million (-29.29%) on March 31, 2025.
- Over the past year, BBIO TTM CFF has dropped by -$51.60 million (-8.88%).
- BBIO TTM CFF is now -37.76% below its all-time high of $850.29 million, reached on June 30, 2020.
Performance
BBIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BBIO Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.8% | -78.4% | -8.9% |
| 3 y3 years | +1.6% | +10000.0% | +180.9% |
| 5 y5 years | +87.7% | -86.3% | -37.0% |
BBIO Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5798.6% | -87.3% | +390.1% | -29.3% | +4129.5% |
| 5 y | 5-year | at high | +5798.6% | -89.0% | +144.5% | -37.8% | +4129.5% |
| alltime | all time | at high | +5798.6% | -89.0% | +144.5% | -37.8% | +4129.5% |
BBIO Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $60.33M(-87.3%) | $529.24M(-29.3%) |
| Dec 2024 | $748.46M(+65.8%) | $473.93M(>+9900.0%) | $748.46M(+177.2%) |
| Sep 2024 | - | $707.00K(-112.3%) | $270.00M(-53.2%) |
| Jun 2024 | - | -$5.73M(-102.0%) | $576.34M(-0.8%) |
| Mar 2024 | - | $279.55M(-6280.6%) | $580.83M(+28.6%) |
| Dec 2023 | $451.54M(-3537.9%) | -$4.52M(-101.5%) | $451.54M(-2.4%) |
| Sep 2023 | - | $307.04M(<-9900.0%) | $462.44M(+194.8%) |
| Jun 2023 | - | -$1.23M(-100.8%) | $156.84M(+14.3%) |
| Mar 2023 | - | $150.25M(+2256.1%) | $137.28M(-1145.2%) |
| Dec 2022 | -$13.13M(-101.8%) | $6.38M(+341.3%) | -$13.13M(-104.3%) |
| Sep 2022 | - | $1.45M(-106.9%) | $305.87M(+81.0%) |
| Jun 2022 | - | -$20.80M(>+9900.0%) | $168.97M(-10.3%) |
| Mar 2022 | - | -$160.00K(-100.0%) | $188.37M(-74.4%) |
| Dec 2021 | $736.45M | $325.38M(-340.2%) | $736.45M(+77.2%) |
| Sep 2021 | - | -$135.46M(+9638.0%) | $415.60M(-25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$1.39M(-100.3%) | $553.83M(-0.4%) |
| Mar 2021 | - | $547.91M(>+9900.0%) | $555.93M(+24.3%) |
| Dec 2020 | $447.19M(+12.1%) | $4.53M(+62.9%) | $447.19M(-7.9%) |
| Sep 2020 | - | $2.78M(+295.7%) | $485.56M(-42.9%) |
| Jun 2020 | - | $703.00K(-99.8%) | $850.29M(+1.3%) |
| Mar 2020 | - | $439.17M(+923.6%) | $839.62M(+110.5%) |
| Dec 2019 | $398.79M(-20.5%) | $42.90M(-88.3%) | $398.79M(-36.7%) |
| Sep 2019 | - | $367.51M(-3786.5%) | $630.06M(+141.6%) |
| Jun 2019 | - | -$9.97M(+503.8%) | $260.83M(-46.1%) |
| Mar 2019 | - | -$1.65M(-100.6%) | $484.20M(-3.5%) |
| Dec 2018 | $501.55M(+343.9%) | $274.17M(<-9900.0%) | $501.55M(+120.6%) |
| Sep 2018 | - | -$1.73M(-100.8%) | $227.37M(-0.8%) |
| Jun 2018 | - | $213.41M(+1259.9%) | $229.10M(+1359.9%) |
| Mar 2018 | - | $15.69M | $15.69M |
| Dec 2017 | $112.98M | - | - |
FAQ
- What is BridgeBio Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for BridgeBio Pharma?
- What is BridgeBio Pharma annual CFF year-on-year change?
- What is BridgeBio Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly CFF year-on-year change?
- What is BridgeBio Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for BridgeBio Pharma?
- What is BridgeBio Pharma TTM CFF year-on-year change?
What is BridgeBio Pharma annual cash flow from financing activities?
The current annual CFF of BBIO is $748.46M
What is the all time high annual CFF for BridgeBio Pharma?
BridgeBio Pharma all-time high annual cash flow from financing activities is $748.46M
What is BridgeBio Pharma annual CFF year-on-year change?
Over the past year, BBIO annual cash flow from financing activities has changed by +$296.92M (+65.76%)
What is BridgeBio Pharma quarterly cash flow from financing activities?
The current quarterly CFF of BBIO is $60.33M
What is the all time high quarterly CFF for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly cash flow from financing activities is $547.91M
What is BridgeBio Pharma quarterly CFF year-on-year change?
Over the past year, BBIO quarterly cash flow from financing activities has changed by -$219.22M (-78.42%)
What is BridgeBio Pharma TTM cash flow from financing activities?
The current TTM CFF of BBIO is $529.24M
What is the all time high TTM CFF for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM cash flow from financing activities is $850.29M
What is BridgeBio Pharma TTM CFF year-on-year change?
Over the past year, BBIO TTM cash flow from financing activities has changed by -$51.60M (-8.88%)